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Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is becoming a global health problem. Bisphenol A (BPA), one
of most widely used environmental chemicals, is suspected to be a contributor to the development NAFLD. This
study was performed to examine the relationship between human BPA levels and risk of NAFLD.
Methods: The data (n = 3476 adults: 1474 men and 2002 women) used in this study were obtained from the
Korean National Environmental Health Survey III (2015-2017). BPA levels were measured in urine samples. NAFLD
was defined using hepatic steatosis index after exclusion of other causes of hepatic diseases.
Results: There was a significant linear relationship between the elevated urinary BPA concentrations and risk of
NAFLD. In a univariate analysis, odds ratio (OR) of the highest quartile of urinary BPA level was 1.47 [95% confidence
interval (CI) 1.11-1.94] compared to the lowest quartile. After adjusted with covariates, the ORs for NAFLD in the
third and fourth quartiles were 1.31 [95% CI 1.03-1.67] and 1.32 [95% CI 1.03–1.70], respectively.
Conclusions: Urinary BPA levels are positively associated with the risk of NAFLD in adults. Further experimental
studies are needed to understand the molecular mechanisms of BPA on NAFLD prevalence.
Keywords: Bisphenol A, Hepatic steatosis index, Nonalcoholic fatty liver disease, Korean adults, Korean national
environmental health survey
Introduction
Nonalcoholic fatty liver (NAFLD) characterized by a
fat accumulation of more than 5% in the liver without
excessive alcohol use, viral hepatitis, and other liver
diseases [1]. It encompassed a wide range of
conditions from nonalcoholic fatty liver to more se-
vere form, nonalcoholic steatohepatitis [2]. It is ex-
pected to be a primary cause of hepatocellular
carcinoma and end-stage liver disease in the next few
decades [3, 4]. The prevalence of NAFLD has been
on the rise over recent decades and is estimated to
be 25.24%, with 24.13% in the United States of Amer-
ica (USA) and 27.37% in Asia [5]. Although Western
dietary consumption and inactive lifestyle contributed
to the increasing rate of NAFLD [6], environmental
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chemicals which are frequently used in everyday ma-
terial, can be the risk factor for NAFLD [7, 8].
Bisphenol A (BPA), one of the most widely used che-
micals, consisted of two phenol rings attached by a me-
thyl bridge, with two methyl groups [9]. It is utilized in
the production of polycarbonate plastic and epoxy resin
that are widely used in various applications including
food packaging, beverage bottle, baby bottle, and paint
[9, 10]. Because of the broad application, human can be
exposed to BPA in their daily life and BPA is detected in
over 90% of the humans [11, 12].
BPA is known to have estrogenic property by binding
to the estrogenic receptors [9]. Many studies have re-
ported the harmful health effects of BPA, including can-
cer, reproductive and development system, and
neurological disorders [9, 13, 14]. Recently, epidemio-
logical studies suggested the association between in-
ternal BPA levels and the risk of obesity and metabolic
disorders, including insulin resistance, type 2 diabetes
mellitus, and hyperlipidemia [15–17]. It might be due to
the upregulation of lipogenic enzymes and transcription
factors such as liver X receptor, the sterol regulatory
element binding protein-1c, and the carbohydrate re-
sponsive element binding protein [18] and the elevation
of oxidative stress [19]. BPA is associated with the
weight gain, fat accumulation, and insulin resistance,
thereby increasing the risk of NAFLD.
Previously, patients with histological diagnosis of
NAFLD showed higher BPA levels in urine compared to
the healthy subjects [7]. The positive association also
showed between urinary BPA levels and NAFLD in USA
population [20]. Nevertheless, the study from the USA
included multiethnic populations; the majority of the
race was non-Hispanic white [20]. Race/ethnicity and
lifestyle could affect the NAFLD prevalence [1, 21]; how-
ever, the relationship between Asians and the risk of
NAFLD prevalence has not been studied.
Therefore, this study was performed to evaluate the as-
sociation between the urinary level of BPA and risk of
NAFLD in Korean adults.
Materials and methods
Study population
This research data was taken from the Korean National
Environmental Health Survey (KoNEHS) III (2015-
2017). KoNEHS is conducted every 3 years from 2009 to
understand the exposure levels of environmental chemi-
cals, examine influential factors, and continuously inves-
tigate the factors of spatiotemporal distribution and
changes in the Korean population. The third stage of
KoNEHS was stratified into regional administrative and
coastal regions and then classified based on the age, sex,
and geographical regions socio-economic status. A total
of 233 sampling units were randomly selected. After
that, 15 households were selected using the systemic ex-
traction method, and about 15 people were surveyed in
each sample area [22].
A total number of 3787 individuals (1648 men and
2139 women) with an age of ≥ 18 years underwent the
questionnaires, anthropometric measurements, and col-
lected urine and blood to analyze the levels of environ-
mental chemicals. Three hundred eleven were excluded
because of missing data for urinary BPA levels (n = 7),
one of alanine aminotransferase (ALT) or aspartate ami-
notransferase (AST) levels (n = 40), and urine creatinine
level (n = 1); those with significant alcohol consumption
(n = 121; who consumed alcohol 3 times more than a
week and 7-9 cups per time in men (n = 112) and who
consumed alcohol 3 times more than a week and 5-6
cups per time in women (n = 19)); those with current
pregnant women (n = 22); those with hepatitis or hepatic
disease (n = 26); and those with AST/ALT ratio > 2 (n =
94). Finally, 3476 participants (1474 men and 2002
women) were included in this analysis (Fig. 1).
Data collection and diagnosis
Demographic and lifestyle characteristics, including age,
sex, drinking and smoking status, physical activity,
monthly household income, education level, marriage, and
medication taking were surveyed through face-to-face in-
terviews. Based on their response, some variables were
categorized as follows: education (less than high school
graduate, high school graduate, and college graduate or
higher), smoking (never, former, and current), physical ac-
tivity levels (no, moderate, and vigorous), monthly house-
hold income (< 2, 2-3, 3-5, and > 5 million Korean won),
and marital status (single, married, and divorced/sepa-
rated). Drinking status was reclassified as never, former,
and current according to the questionnaires: did not drink
at all (never), had a drinking experience but did not drink
at all in the last year (former), and had a drinking experi-
ence and drink more than once a week (current).
Participants with diagnosis of hepatitis or hepatic steato-
sis and who were presently under treatment or taking drugs
were regarded as one that has the hepatic disease. Hyper-
tension was defined by self-reporting a history of hyperten-
sion or taking antihypertensive medications. Diabetes
mellitus (DM) was defined by self-reporting a history of
DM or taking anti-diabetic medications. Hyperlipidemia
was defined as a self-reported history of hyperlipidemia, use
of anti-hyperlipidemic medication, high-density lipoprotein
cholesterol ≤ 40 mg/dL, and triglyceride (TG) ≥ 240. Body
mass index (BMI) was calculated as the body weight (kg)
divided by height squared (m2).
Urinary bisphenol A concentrations
Spot urine samples were collected from participants and
stored at 0-4 °C immediately, and subsequently frozen at
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−20 °C according to the guideline of National Institute
of Environmental Research [23]. Urinary BPA were mea-
sured using ultra-performance liquid chromatography-
mass spectrometry (Xevo TQ-S, Waters, Milford, MA,
USA) [24]. Values below the detection limit were divided
by the square root of 2.
Laboratory evaluations
Blood samples were collected from participants at the
same time with the urine samples. The samples were
centrifuged at 3500 rpm to separate the serum, and
stored at 0-4 °C. The separated serum was aliquoted and
frozen at −20 °C according to the guideline of National
Institute of Environmental Research [23]. AST, ALT,
and gamma-glutamyl transpeptidase (γ-GTP) were mea-
sured in serum samples [25]. The reference values were
AST < 34U/L., ALT 10 - 49U/L, and γ-GTP < 73 U/
L for men and γ-GTP < 38 U/L for women.
NAFLD evaluations
The hepatic steatosis index (HSI) is an efficient non-
invasive biomarker for NAFLD [26]. The variables in the
HSI formula were levels of ALT, AST, BMI, sex, and
presence of DM. Subjects were categorized into NAFLD
and non-NAFLD using the published cut-off value of 36.
HSI ¼ 8 ALT
AST
ratioþ BMI ðþ2; i f diabetes mellitues;þ2; i f f emaleÞ
Since elevated AST, ALT, and γ-GTP were also used
for NAFLD assessment [27–29], we defined abnormal
AST, ALT, and γ-GTP based on the reference value.
Statistical analysis
The average and standard error (continuous variables),
and frequency (categorical variables) were provided in
non-NAFLD and NAFLD based on the hepatic steatosis
index score. Sample weights were included in order to
reconstruct the data at the level of the entire population
of Korea. The log transformation was performed because
the distribution of urinary BPA concentrations was
skewed to the right. BPA concentrations were catego-
rized into quartiles based on the weighted sample distri-
bution. The weighted mean (continuous variables) and
weighted frequencies (categorical variables) in general
characteristics were described by the BPA quartiles. The
general characteristics were compared using the t test
and an analysis of variance (continuous variable) or χ2
test (categorical variables).
A multivariate logistic regression analysis was per-
formed to evaluate the relationship between urinary
BPA levels and NAFLD. Covariates of age, sex, drink-
ing, smoking, physical activity, monthly household in-
come, education, marriage, and urine creatinine were
included in the regression model. Because BMI is
used in the HSI formula, it is not included in multi-
variate analysis as an independent variable to avoid
collinearity. In this formula, 2 points was added in fe-
male to adjust the lower BMI in women compared to
men. Also, because DM was an independent risk fac-
tor of NAFLD, 2 point was added in the subject with
DM [26]. Thus, sex and DM were used as independ-
ent variables in multivariate analysis. Data analyses
were performed using STATA (version 16.0 StataCorp
LP College Station, TX, USA). P values < 0.05 were
considered significant.
Fig. 1 Study population in the present study obtained from the Korean National Environmental Health Survey III (2015-2017)
An et al. Environmental Health and Preventive Medicine           (2021) 26:91 Page 3 of 9
Results
General characteristics of study population
The general characteristic of samples was shown in Ta-
bles 1 and 2. Respondents were divided into two cat-
egories, non-NAFLD and NAFLD, based on the HSI
(Table 1). Of 3476 participants, 2561 (73.68%) had HSI
value under 36, and 915 (26.32%) had HSI value over 36
or higher. The mean age was 52.67 years old in non-
NAFLD and 53.78 years old in NAFLD. Drinking status,
physical activity, monthly income, education, and marital
status was significantly different between non-NAFLD
and NAFLD group (p = 0.018, p = 0.005, p = 0.037, p <
0.001, and p = 0.043, respectively). Participants in the
NAFLD group had significantly higher levels in AST,
ALT, γ-GTP, and BMI (all p < 0.001).
Table 2 indicated the general characteristics of study
participants according to urinary BPA concentration.
BPA concentrations were log-transformed because of
Table 1 General characteristics of study participants according to hepatic steatosis index score
Total (n = 3476) non-NAFLD (n = 2561) NAFLD (n = 915) p value
Age, year 52.96 ± 0.25 52.67 ± 0.29 53.78 ± 0.46 0.090
Gender (%, men) 1474 (42.41) 1070 (41.78) 404 (44.15) 0.213
BMI, kg/m2 24.61 ± 0.05 23.23 ± 0.04 28.47±0.10 < 0.001
Drinking status, n (%) 0.018
Never 715 (20.57) 502 (19.60) 213 (23.28)
Former 439 (12.63) 314 (12.26) 125 (13.66)
Current 2322 (66.80) 1745 (68.14) 577 (63.06)
Smoking status, n (%) 0.727
Never 2278 (65.54) 1667 (65.48) 602 (65.68)
Former 679 (19.53) 507 (19.80) 172 (18.80)
Current 519 (14.93) 377 (14.72) 142 (15.52)
Physical activity, n (%) 0.005
No 1888 (54.32) 1350 (52.71) 538 (58.80)
Moderate 274 (7.88) 205 (8.00) 69 (7.54)
Vigorous 1314 (37.80) 1006 (39.28) 308 (33.66)
Monthly household income, n (%) 0.037
< 2 million Korean Won 1308 (37.63) 944 (36.86) 364 (39.78)
2-3 million Korean Won 733 (21.09) 523 (20.42) 210 (22.95)
3-5 million Korean Won 873 (25.12) 662 (25.93) 209 (22.84)
> 5 million Korean Won 562 (16.17) 430 (16.79) 132 (14.43)
Education, n (%) < 0.001
< High school 1172 (33.72) 800 (31.24) 372 (40.66)
High school 1220 (35.10) 941 (36.74) 279 (30.49)
College or higher 10.84 (31.19) 820 (32.02) 264 (28.85)
Marital status, n (%) 0.043
Single 397 (11.42) 310 (12.10) 87 (9.51)
Married 2681 (77.13) 1971 (76.96) 710 (77.60)
Divorced or separated 398 (11.45) 280 (10.93) 118 (12.90)
AST 25.97 ± 0.17 24.95 ± 0.18 28.84 ± 0.41 < 0.001
ALT 24.86 ± 0.26 20.82 ± 0.18 36.17 ± 0.74 < 0.001
γ-GTP 29.78 ± 0.57 26.00 ± 0.61 40.36 ± 1.29 < 0.001
Comorbidity, n (%)
Hypertension 798 (22.96) 474 (18.51) 324 (35.41) < 0.001
Diabetes mellitus 309 (8.89) 146 (5.70) 163 (17.81) < 0.001
Hyperlipidemia 1211 (34.84) 734 (28.66) 477 (52.13) < 0.001
NAFLD nonalcoholic fatty liver disease, BMI body mass index, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP gamma-glutamyl transpeptidase
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the skewness. The transformed BPA level was classified
into quartiles based on the weighted sample distribution.
The range of BPA concentration (μg/L) is shown as fol-
lows: min-0.50 in the first quartile, 0.50-1.26 in the sec-
ond quartile, 1.26-2.67 in the third quartile, and 2.67-
max in the fourth quartile. Gender, BMI, smoking status,
AST, γ-GTP, and hyperlipidemia were found to be sta-
tistically significant among the levels of BPA (p < 0.001,
p < 0.001, p < 0.001, p = 0.048, p = 0.015, and p = 0.025,
respectively).
Distribution of urinary BPA concentrations
The urinary BPA levels were shown in Table 3 between
the non-NAFLD group and NAFLD group. The geomet-
ric mean (GM) concentration of BPA in NAFLD group
(2.56 μg/L) was significantly higher than in non-NAFLD
Table 2 General characteristics of study participants according to urinary bisphenol A concentrations
Quartile 1 (n = 888) Quartile 2 (n = 880) Quartile 3 (n = 860) Quartile 4 (n = 848) P value
Age (year) 47.60 ± 0.96 47.23 ± 0.93 47.08 ± 0.88 45.82 ± 0.74 0.135
Gender (%, men) 43.98 ± 1.87 45.03 ± 1.83 50.84 ± 2.24 56.02 ± 1.91 < 0.001
BMI (kg/m2) 23.87 ± 0.14 24.17 ± 0.16 24.61 ± 0.19 24.73 ± 0.17 < 0.001
Drinking status (%) 0.056
Never 17.13 ± 1.80 17.37 ± 1.73 14.72 ± 1.51 13.71 ± 1.46
Former 11.64 ± 1.34 12.83 ± 1.59 10.27 ± 1.59 10.91 ± 1.38
Current 71.21 ± 2.08 69.77 ± 2.11 75.00 ± 1.95 75.37 ± 1.98
Smoking status (%) < 0.001
Never 70.06 ± 1.71 65.52 ± 1.91 59.79 ± 2.53 58.71 ± 2.42
Former 16.16 ± 1.51 18.49 ± 1.67 20.25 ± 1.80 18.24 ± 1.83
Current 13.77 ± 1.76 15.97 ± 2.09 20.24 ± 1.82 23.03 ± 2.10
Physical activity (%) 0.099
No 52.75 ± 2.34 54.60 ± 2.46 54.01 ± 2.34 60.38 ± 2.05
Moderate 9.68 ± 1.42 6.44 ± 1.07 7.71 ± 1.19 5.79 ± 0.96
Vigorous 37.56 ± 2.61 38.95 ± 2.42 38.27 ± 2.16 33.82 ± 2.15
Monthly household income (%) 0.943
< 2 million Korean Won 28.53 ± 2.63 27.09 ± 2.42 25.90 ± 1.89 28.94 ± 2.66
2-3 million Korean Won 19.55 ± 2.32 25.18 ± 2.14 22.59 ± 2.14 20.34 ± 1.97
3-5 million Korean Won 30.38 ± 2.72 25.97 ± 2.53 30.14 ± 2.19 29.79 ± 2.72
> 5 million Korean Won 21.52 ± 2.64 21.75 ± 2.34 21.35 ± 2.33 20.91 ± 2.14
Education (%) 0.996
< High school 22.41 ± 2.26 20.30 ± 1.90 21.73 ± 1.92 20.25 ± 1.82
High school 35.01 ± 2.13 38.62 ± 2.07 38.93 ± 2.64 38.25 ± 2.32
College and more 42.56 ± 2.71 41.07 ± 2.21 39.33 ± 2.66 41.49 ± 2.53
Marital status (%) 0.797
Single 21.02 ± 2.29 21.65 ± 2.18 20.27 ± 2.25 22.42 ± 2.14
Married 71.13 ± 2.35 69.49 ± 2.39 71.26 ± 2.33 69.69 ± 2.23
Divorced or separated 7.84 ± 1.16 8.85 ± 1.26 8.45 ± 1.32 7.87 ± 1.13
AST 25.57 ± 0.35 24.79 ± 0.32 25.90 ± 0.82 25.42 ± 0.45 0.048
ALT 24.70 ± 0.62 24.09 ± 0.67 25.91 ± 1.19 26.26 ± 0.72 0.729
γ-GTP 28.18 ± 1.25 28.49 ± 1.25 32.20 ± 1.88 32.57 ± 1.87 0.015
Comorbidity (%)
Hypertension 16.78 ± 1.21 17.06 ± 1.62 17.29 ± 1.40 14.40 ± 1.54 0.257
Diabetes mellitus 6.44 ± 0.98 4.65 ± 0.63 6.02 ± 1.13 7.39 ± 1.10 0.359
Hyperlipidemia 27.92 ± 2.11 30.54 ± 2.00 31.41 ± 2.56 34.44 ± 2.12 0.025
BMI body mass index, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP, gamma-glutamyl transpeptidase. Data were shown as the weighted
mean or frequency ± standard errors as appropriated
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group (2.24 μg/L) (p = 0.001). The 25th, 50th, and 75th
levels of urinary BPA were 0.48 μg/L, 1.21 μg/L, and
2.56 μg/L in non-NAFLD group, and 0.57 μg/L, 1.52 μg/
L, and 2.96 μg/L in NAFLD group.
Prevalence of NAFLD and abnormal ALT, AST, and γ-GTP
according to urinary BPA levels
The number of NAFLD based on HSI, and abnormal
ALT, AST, and γ-GTP were presented in Table 4. The
prevalence of NAFLD based on HSI and abnormal ALT
were increased in accordance with the increase of urin-
ary BPA concentrations (p = 0.002 and p = 0.023, re-
spectively). However, there were no significant
relationships between the number of abnormal AST and
γ-GTP with urinary BPA levels.
The association between urinary BPA concentrations and
NAFLD prevalence
Odds ratio (OR) and 95% CI for NAFLD based on HSI
according to BPA levels were presented in Table 5. A lo-
gistic regression was conducted based on the BPA quar-
tile, using the first quantile as the reference group.
In a crude model, the fourth quartile showed a signifi-
cantly higher OR of HSI (1.47 [95% CI 1.11-1.94]).
When adjusting age, gender and urine creatinine (model
1), OR in the fourth quartile was 1.31 (95% CI 0.99-
1.75). Hence, there was no significant association.
With an additional adjustment of the socio-economic
values (model 2), the third and fourth quartiles showed
higher ORs of NAFLD by HSI compared to the first
quartile (1.28 [95% CI 1.02-1.60] and 1.37 [95% CI 1.08-
1.73], respectively).
Further adjusting comorbidities such as hypertension,
DM, and hyperlipidemia (model 3), ORs in the third and
fourth quartiles were higher than in reference group
(1.31 [95% CI 1.03-1.67] and 1.32 [95% CI 1.03-1.70]
respectively).
Results of trend tests for the correlation between
NAFLD and BPA were p < 0.05 regardless of adjust-
ments (crude, model 1, model 2, and model 3).
Discussion
This study was conducted to evaluate the association be-
tween urinary BPA level and NAFLD base on HSI score
in the Korean population. The higher risk of NAFLD ac-
cording to HSI was significantly associated with higher
urinary BPA concentration. Exposure of BPA presented
by urine BPA level linearly correlated with NAFLD oc-
currence in both unadjusted and adjusted models.
BPA is widely used in the synthesis of consumer prod-
ucts, including food and beverage containers, baby bot-
tle, and dental sealants [9, 10]. Human are exposed to
BPA through oral administration, inhalation and dermal
absorption [30]. Once BPA enters to body, it binds to
glucuronic acid and converts to BPA glucuronide in the
liver and gut [9], and the BPA glucuronides are primarily
excreted through urine [31]. Although some prospective
studies used in both urine and blood samples to measure
BPA levels [7, 32], urine samples were used to demon-
strate the BPA exposure in population based studies be-
cause of the relatively ease to collect the biological
samples compared to the blood.
BPA has been suggested that the positive relationship
with obesity and metabolic disease in healthy adults [15,
16, 33]. Obesity is well-known factor in liver abnormal-
ities, including NAFLD [34] that is characterized by an
increase of hepatic TG content with or without inflam-
mation and fibrosis [1, 2]. Recent epidemiologic studies
Table 3 Distributions of urinary bisphenol A levels (BPA, μg/L)
in the study population
BPA conc. (μg/L) Total non-NAFLD NAFLD P value
GM (GSE) 2.32 (0.07) 2.24 (0.08) 2.56 (0.15) 0.001
Percentile
Min 0.05 0.05 0.05
25th 0.5 0.48 0.57
50th 1.26 1.21 1.52
75th 2.66 2.56 2.96
Max 111.31 111.31 86.78
NAFLD nonalcoholic fatty liver disease, GM geometric mean, GSE geometric
standard error
Table 4 Prevalence of NAFLD and abnormal ALT, AST, and γ-GTP activities according to urinary bisphenol A levels
Quartile 1 (n = 888) Quartile 2 (n = 880) Quartile 3 (n = 860) Quartile 4 (n = 848) P value
NAFLD Actual number 201 214 242 258 0.002
Weighted frequency (95% CI) 21.83 (18.42-25.68) 22.14 (18.88-25.78) 25.55 (21.64-29.90) 29.18 (25.48-33.19)
Abnormal ALT Actual number 83 88 87 102 0.023
Weighted frequency (95% CI) 10.41 (8.22-13.11) 12.27 (9.36-15.93) 11.25 (8.80-14.27) 15.34 (12.53-18.66)
Abnormal AST Actual number 110 82 91 10 0.872
Weighted frequency (95% CI) 12.24 (9.62-15.45) 7.59 (5.67-10.09) 9.99 (8.03-12.35) 11.77 (9.45-14.58)
Abnormal γ-GTP Actual number 104 89 99 95 0.844
Weighted frequency (95% CI) 10.86 (8.54-13.72) 9.29 (6.97-12.29) 12.05 (9.42-15.29) 10.31 (8.06-13.09)
NAFLD nonalcoholic fatty liver disease, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP gamma-glutamyl transpeptidase
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have showed an association between urinary BPA levels
and the risk of NAFLD [7, 20]. It seems that BPA could
promote lipid accumulation in the liver as well as
obesity.
Experimental studies have suggested the underlying
mechanism for the hepatic lipid accumulation due to BPA
exposure. BPA-treated mice showed the increase of lipid
accumulation in the liver through the activation of lipo-
genic enzymes, including acetyl-CoA carboxylase, fatty
acid synthase, stearoyl-CoA desaturase-1, and sterol regu-
latory element binding factor 1 [18, 35]. In addition, the
elevation of inflammation might be closely associated with
the appearance and progression of liver disease [7, 19, 36].
Thus, BPA could induce hepatic steatosis through modu-
lated by de novo lipogenesis and inflammation.
Previously, BPA levels in urine and blood in NAFLD
patients was significantly higher than healthy subjects
[7]. In US population based study, the positive associ-
ation also showed between urinary BPA concentrations
and the prevalence of NAFLD [20]. Similar with the pre-
vious studies, higher levels of urinary BPA were associ-
ated with NAFLD prevalence in Korean adults. Although
BPA is metabolized and excreted over 90% within 24 h
after administration [37], most people can be exposed to
BPA through their life. In addition, internal BPA levels
can vary depending on the lifestyle, diet, and living en-
vironment [38]. Thus, further study is needed on
whether the reduction of BPA exposure can decrease the
incidence of NAFLD.
In addition, the prevalence of abnormal ALT was in-
creased according to increase of BPA levels, but not in
AST and γ-GTP. Similar with our result, serum ALT
levels was relatively higher in NAFLD patients than
healthy people [28, 39]. Because the increase of hepatic
lipid accumulation can induce the toxic effects on hepato-
cytes [40], NAFLD may induce the elevation of liver en-
zymes, including ALT, AST, and GGT. It seems that
exposure to BPA might increase the risk of liver damages.
To the best of our knowledge, this is the first study to
establish the association between urinary BPA level and
NAFLD prevalence in the Korean population. In addition,
because study was performed from the data that can rep-
resent the national population, these results could
generalize to the population. However, there remains
some limitation. First, HSI score is used to define NAFLD.
Liver biopsy and abdominal ultrasound might be more ap-
propriate to find liver steatosis. However, those are not
feasible in population based large-scale study because of
the invasiveness and cost issue. HSI is a noninvasive tool
to predict the presence of NAFLD using anthropometric
and laboratory parameters, including BMI, AST, and ALT
[26]. HSI score with < 36 or > 36 had 93.1% sensitivity to
rule-out the absence of NAFLD and 92.4% specificity to
detect the presence of NAFLD. Nevertheless, there is still
a problem with classification errors, because 30 ≤ HSI ≤ 36
was considered as the non-NAFLD group. However, it is
inevitable to statistical analysis. Second, the amount of al-
cohol consumption (g/day) could not estimate because
KoNEHS offered the drinking times in the last month and
the number of glass per times. In this study, men who
consumed alcohol 3 times more than a week and 7-9
glasses per time, and women who consumed alcohol 3
times more than a week and 5-6 glasses per time were de-
fined as heavy drinker by referring to previous study [41].
Third, it could not evaluate the causal relationship be-
tween urinary BPA level and NAFLD because of a cross-
sectional analysis. Additional studies are needed to deter-
mine the contribution of BPA on NAFLD prevalence.
Fourth, BPA levels were measured using spot urine sam-
ples. After administration, most of BPA is eliminated
within 24 h via urine [37]; thus, temporal variation of BPA
levels in subjects can be raised. Nevertheless, KoNEHS
randomly collected the spot urine sample from a large
population according to the survey guideline [23]. It may
reflect the average BPA levels in population.
In conclusion, the result of this study based on a rep-
resentative Korean population indicated that there is
positive association between urine BPA concentration
reflecting BPA exposure and risk of increasing NAFLD.
As BPA has been observed to be associated with an in-
creased prevalence of NAFLD, it would be desirable to
reduce BPA exposure.
Table 5 Multivariate analysis for NAFLD according to urinary bisphenol A levels
Crude Model 1 Model 2 Model 3
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Quartile 1 1 0.002* 1 0.035* 1 0.003* 1 0.010*
Quartile 2 1.01 (0.74-1.39) 0.913 1.00 (0.73-1.37) 0.955 1.09 (0.87-1.36) 0.435 1.08 (0.85-1.36) 0.510
Quartile 3 1.22 (0.89-1.68) 0.203 1.16 (0.84-1.58) 0.346 1.28 (1.02-1.60) 0.032 1.31 (1.03-1.67) 0.025
Quartile 4 1.47 (1.11-1.94) 0.006 1.31 (0.99-1.75) 0.058 1.37 (1.08-1.73) 0.007 1.32 (1.03-1.70) 0.026
NAFLD nonalcoholic fatty liver disease, OR odds ratio, CI confidence interval
*p values were shown the test of trend of odds
Crude: Hepatic steatosis index, bisphenol A
Model 1: Crude + age, gender, creatinine
Model 2: Model 1 + smoking, drinking, exercise, marital status, education, income
Model 3: Model 2 + hypertension, diabetes mellitus, hyperlipidemia
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